Concord Medical Services ADR
(CCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,575 | -37,714 | -43,909 | -38,180 | -12,239 |
| Depreciation Amortization | 8,095 | 7,945 | 14,556 | 18,581 | 24,443 |
| Income taxes - deferred | -3,226 | 1,091 | 1,952 | 3,185 | -67 |
| Accounts receivable | 513 | 7,037 | 6,671 | 1,429 | 6,683 |
| Accounts payable and accrued liabilities | 408 | 77 | 777 | 1,003 | -112 |
| Other Working Capital | -10,681 | 21,472 | 8,232 | -9,128 | -42,977 |
| Other Operating Activity | 27,408 | -5,522 | 15,829 | 11,864 | -2,769 |
| Operating Cash Flow | $-28,058 | $-5,614 | $4,108 | $-11,246 | $-27,038 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,155 | 23,686 | N/A | 8,642 | -9,262 |
| PPE Investments | -23,465 | -7,656 | -7,472 | -9,646 | -7,211 |
| Net Acquisitions | -60,409 | -76,902 | -2,694 | 1,872 | -26,451 |
| Purchase Of Investment | -15,099 | -2,182 | -15,031 | -26,141 | -15,602 |
| Purchase Sale Intangibles | -83 | 114 | -115 | -138 | N/A |
| Other Investing Activity | -63,095 | -82,442 | -22,912 | 14,493 | -1,846 |
| Investing Cash Flow | $-153,913 | $-145,496 | $-48,109 | $-10,780 | $-60,372 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 41,010 | 105,701 | -14,925 | 71,666 | 36,000 |
| Debt Issued | 134,219 | 94,091 | 88,116 | 2,376 | 114,205 |
| Debt Repayment | -36,460 | -108,801 | -61,304 | -41,344 | -53,717 |
| Common Stock Repurchased | N/A | N/A | N/A | -4,378 | -3,045 |
| Dividend Paid | N/A | N/A | N/A | -41,168 | N/A |
| Other Financing Activity | -65,043 | 83,985 | 17,994 | -6,073 | -2,302 |
| Financing Cash Flow | $73,726 | $174,976 | $29,881 | $-18,921 | $91,141 |
| Exchange Rate Effect | 166 | 67 | 24 | -1,619 | -2,689 |
| Beginning Cash Position | 118,753 | 96,310 | 29,188 | 69,918 | 73,896 |
| End Cash Position | 10,674 | 120,243 | 15,092 | 27,352 | 74,938 |
| Net Cash Flow | $-108,079 | $23,933 | $-14,096 | $-42,566 | $1,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,058 | -5,614 | 4,108 | -11,246 | -27,038 |
| Capital Expenditure | -33,424 | -24,085 | -14,026 | -11,367 | -7,376 |
| Free Cash Flow | -61,482 | -29,699 | -9,918 | -22,613 | -34,414 |